[Novosti Biological: bivalirudin for injection obtains Drug Registration Certificate] Science and Technology Innovation Board Daily reported on the 13th that the company recently received a "Drug Registration Certificate" approved and issued by the State Drug Administration. Bivalirudin for injection is a thrombin inhibitor mainly used in patients with unstable angina pectoris undergoing percutaneous transluminal coronary angioplasty (PTCA) and patients undergoing percutaneous coronary intervention (PCI).